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Abstract
We first identified and isolated cellular subpopulations with
characteristics of mesenchymal progenitor cells (MPCs) in
osteoarthritic cartilage using fluorescence-activated cell sorting
(FACS). Cells from osteoarthritic cartilage were enzymatically
isolated and analyzed directly or after culture expansion over
several passages by FACS using various combinations of
surface markers that have been identified on human MPCs
(CD9, CD44, CD54, CD90, CD166). Culture expanded cells
combined and the subpopulation derived from initially sorted
CD9+, CD90+, CD166+ cells were tested for their osteogenic,
adipogenic and chondrogenic potential using established
differentiation protocols. The differentiation was analyzed by
immunohistochemistry and by RT-PCR for the expression of
lineage related marker genes. Using FACS analysis we found
that various triple combinations of CD9, CD44, CD54, CD90
and CD166 positive cells within osteoarthritic cartilage account
for 2–12% of the total population. After adhesion and cultivation
their relative amount was markedly higher, with levels between
24% and 48%. Culture expanded cells combined and the
initially sorted CD9/CD90/CD166 triple positive subpopulation
had multipotency for chondrogenic, osteogenic and adipogenic
differentiation. In conclusion, human osteoarthritic cartilage
contains cells with characteristics of MPCs. Their relative
enrichment during in vitro cultivation and the ability of cell
sorting to obtain more homogeneous populations offer
interesting perspectives for future studies on the activation of
regenerative processes within osteoarthritic joints.
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Introduction
Mesenchymal progenitor cells (MPCs) from bone marrow
are able to differentiate in various types of connective tis-
sue, including cartilage, bone and adipose tissue [1-3].
This led to more precise characterization of these cells by
analysis of cell surface markers and differentiation related
gene expression [4-9]. In parallel, it was recognized that
MPCs not only reside in bone marrow but also in various
other connective tissues, such as periost, and adipose and
muscle tissue [5,6,10-14]. Cells within the joint that are
capable of differentiating into chondrocytes, osteoblasts
and adipocytes were recently described in synovia, patellar
fat pad and articular cartilage [4,5,15-18].
In the present study we purified progenitor-like cells from
the cartilage of human osteoarthritic joints and showed that
these cells are capable of proliferation and osteogenic, adi-
pogenic and chondrogenic lineage progression. Those
cells could be distinguished from articular chondrocytes by
simultaneous staining with several triple combinations of
cell surface antigens [4-6]. We used these marker sets for
quantification of MPCs by flow cytometric analysis in the
original cell population and after in vitro cultivation. Finally,
we sorted these cells according to the expression of tripli-
cate surface markers and demonstrated that this subpopu-
lation is capable of osteogenic, adipogenic and
chondrogenic differentiation. These findings should pro-
vide a basis for identification of MPCs in articular cartilage
COMP = cartilage oligomeric matrix protein; DMEM = Dulbecco's modified Eagle's medium; FACS = fluorescence-activated cell sorting; FCS = fetal 
calf serum; FITC = fluorescein isothiocyanate; MPC = mesenchymal progenitor cell; OC = osteoarthritic cartilage; PBS = phosphate-buffered saline; 
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and for studies of their roles in joint physiology and disease,
as well as in induction of regenerative processes within
osteoarthritic joints.
Methods
Patient characteristics
Human osteoarthritic cartilage (OC) was obtained during
routine surgical procedures with informed consent from
seven patients with end-stage osteoarthritis, in accordance
with the terms of the Ethics Committee of the University of
Ulm. The age of the donors ranged from 55 to 89 years
(mean 74 years). The diagnosis was based on clinical and
radiological criteria. None of the donors had received corti-
costeroids or cytostatic drugs during the previous few
months. Patients with systemic inflammatory diseases such
as rheumatoid arthritis or spondyloarthropathies were
excluded.
Cell isolation, expansion and cryopreservation
For cell culture samples, pure cartilage from regions with
macroscopically mild-to-moderate osteoarthritic changes
was extracted and then subjected to the following: two
rinses with phosphate-buffered saline (PBS; Invitrogen,
Karlsruhe, Germany) supplemented with antibiotic solution
(100 units/ml penicillin, 100 µg/ml streptomycin; Bio-
chrom, Berlin, Germany); fine mincing and digestion with
0.2% pronase (Roche, Mannheim, Germany) for 45 min at
37°C; and two further washes followed by enzymatic diges-
tion overnight at 37°C in 0.025% collagenase (Roche).
After filtration through a 40 µm pore membrane, the cells
were washed twice in Dulbecco's modified Eagle's medium
(DMEM; Invitrogen) containing 10% fetal calf serum (FCS;
Biochrom) and antibiotic solution (100 units/ml penicillin,
100 µg/ml streptomycin), and counted and plated at low
density (5 × 104 isolated cells/cm2). DMEM supplemented
with 10% FCS was used as a medium during the prolifera-
tion phase. The cultures were incubated at 37°C in a
humidified 5% carbon dioxide atmosphere, and media were
changed three times a week. Cultures were split by trypsin
treatment (0.05% trypsin, 0.02% EDTA; Biochrom) at 75%
confluence.
Flow cytometry analysis of cells
Either isolated cells from OC were directly used for flow
cytometric analysis or cells were used after adherence and
cultivation, as described above. Cells were washed twice
with PBS containing 1% FCS and 0.02% sodium azide
(Sigma, Taufkirchen, Germany). The cells were incubated
with 1 µg/106 cells for each mouse anti-human monoclonal
antibody that had been directly conjugated to a fluoro-
chrome or biotinylated in the dark for 20 min on ice. The
antibodies used are listed in Table 1. After a washing step,
second staining for biotin-conjugated monoclonal antibod-
ies was done with streptavidin peridinin chlorophyll protein
conjugate in a working titre of 1:100. After 30 min in the
dark on ice, cells were washed again twice with PBS buffer
before flow cytometric analysis. MPCs were characterized
by three-colour immunoflourescence and 2 × 104 cells per
sample were analyzed on a Becton Dickinson FACScalibur
system using CELLQuest software (Becton Dickinson,
Heidelberg, Germany). Dead cells were excluded by pro-
pidium iodide (Sigma) staining. Cells were gated on for-
ward and side scatter to exclude debris and cell
aggregates. To calculate the percentages of cells staining
positive for antigen-specific fluorescein isothiocyanate
(FITC)-conjugated, phycoerythrin (PE)-conjugated, allophy-
cocyanine-conjugated, or biotin-conjugated monoclonal
antibodies, a maximum of 2% positive cells by staining with
isotype control antibody was allowed and therefore used to
calibrate the channel display by setting the markers.
CD133/1 (AC133)-biotin and CD133/2 (AC141)-biotin
were obtained from Miltenyi Biotec (Bergisch-Gladbach,
Germany). All other antibodies and the isotype controls
FITC mouse IgG1κ, R-PE mouse IgG1κ, biotin mouse IgG1κ
and biotin mouse IgG2b  were provided by Becton
Dickinson.
Fluorescence-activated cell sorting
For cell sorting, native isolated cells from OC were stained
with saturating concentrations of CD9-FITC, CD90-allo-
phycocyanine and CD166-PE. Single cells were sorted
into the flow cytometry tubes (Becton Dickinson) using a
Becton-Dickinson FACStarplus cell sorter. OC cells were
gated based on forward and side scatter, and the frequen-
cies of CD90+ and CD166+ cells were determined follow-
ing a second gate on CD9+ cells.
In vitro chondrogenesis assay
Pellet cultures were performed as described previously
[15]. Briefly, expanded OC-derived cells and sorted OC
cells were released by trypsin treatment, counted and
resuspended in 15 ml polypropylene conical tubes at a
density of 2 × 105–106, and short spun down at 500 g. The
medium was changed to 500 µl DMEM with 10% FCS, 1%
antibiotic mix (penicillin/streptomycin), 37.5 µg/ml (100
µmol/l) ascorbate-2 phosphate, and 10-7 mol/l dexametha-
sone. Pellet cultures were incubated with 10 ng/ml recom-
binant human transforming growth factor-β3  (Tebu,
Offenbach, Germany) during chondrogenesis. All cultures
were maintained at 37°C in 5% carbon dioxide, and the
medium was changed every third day. After 3 weeks the
samples were used for histological and immunohistological
studies, and for RT-PCR gene expression analysis.
Histology and immunohistochemistry
The samples were fixed in 4% para-formaldehyde and
embedded in paraffin. For histological evaluation, sections
were deparaffinized and either stained with haematoxylin or
Alcian blue at pH 2.5, with additional Kernechtrot counter-
staining, according to standard protocols.Available online http://arthritis-research.com/content/6/5/R422
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For immunohistochemical analysis of collagen types I and
II, and cartilage oligomeric matrix protein (COMP) in chon-
drogenic differentiated pellet cultures, 3 µm sections were
deparaffinized and treated with 1 mg/ml pepsin (Sigma) in
0.5 mol/l acetic acid for collagen type I, with 500 µg/ml pro-
teinase K in Tris-buffered saline (Sigma) for collagen type
II, and 1 mg/ml hyaluronidase (Sigma) and proteinase K
(500 µg/ml in Tris-buffered saline) for COMP at room tem-
perature for different times to facilitate antibody access.
Endogenous peroxidase was blocked by 3% H2O2. The
slides were incubated for 30 min in blocking reagent in
order to prevent nonspecific binding. Sections were then
incubated overnight at 4°C with primary antibodies. Rabbit
anti-human polyclonal antibodies against collagen type I
(DPC Biermann, Bad Nauheim, Germany), collagen type II
(DPC Biermann), and COMP (kindly provided by Dr F
Zaucke and Professor M Paulsson, Institute for Biochemis-
try II, University of Köln, Köln, Germany) were used. The
antibody directed against collagen type I was diluted
1:1000, the antibody against collagen type II was diluted
1:400, and the antibody against COMP was used at a
1:300 dilution in 1% bovine serum albumin in PBS. Bioti-
nylated anti-mouse, anti-rabbit secondary antibodies were
used for 30 min incubation followed by streptavidin treat-
ment (30 min). Finally, sections were stained using the AEC
kit (DAKO, Hamburg, Germany), in accordance with the
manufacturer's instructions. Nuclei were counterstained
with haematoxylin.
In vitro adipogenesis assay
For adipogenic differentiation, 1 × 105 cells were washed
and plated in six-well plates (Becton Dickinson). Adipo-
genic differentiation was induced with 1 µmol/l dexameth-
asone, 1 µg/ml insulin, 0.5 mmol/l isobutyl-methylxanthine
and 100 µmol/l indomethacin. Stimulation was carried out
for 2 weeks with the media changed every 3–4 days and
supplements added fresh to each culture. Differentiation
was confirmed by RT-PCR gene expression analysis.
In vitro osteogenesis assay
After trypsin treatment 2 × 104 cells were washed in DMEM
with 10% FCS, and cultured in six-well plates (Becton
Dickinson). Medium for osteogenic differentiation contain-
ing DMEM with 0.1 µmol/l dexamethasone, 10 mmol/l β-
glycerophosphate and 50 µg/ml ascorbic acid was
changed every third day, as described previously [19].
Osteogenic differentiation was confirmed by RT-PCR gene
expression analysis.
Reverse transcription polymerase chain reaction and 
analysis of gene expression
Total RNA was isolated from fresh OC, which was cut in
the operating room into small pieces, immediately frozen in
liquid nitrogen and stored at -80°C. For RNA extraction of
native tissue, OC samples were homogenized using a Dis-
membrator (Braun Biotech, Melsungen, Germany). Both
OC and cultivated cells were lysed in 600 µl lysis buffer
with 6 µl mercaptoethanol, by using the RNeasy® system
and reverse transcription was done with Omniscript™ RT
Kit (all Qiagen, Hilden, Germany), in accordance with the
manufacturer's instructions.
PCR reactions were performed using a Robocycler® (Strat-
agene, Amsterdam, The Netherlands) using HotStarTaq™
Master Mix Kit (Qiagen). PCR was performed under linear
conditions using the following cycle profile: initial incuba-
tion (15 min at 95°C); followed by 30 cycles of annealing
(45 s at 60°C), extension (45 s at 72°C) and denaturation
(60 s at 94°C); and terminating with 15 min at 72°C. PCR
products were separated on a 1.5% agarose gel and
stained with ethidium bromide, visualized and digitalized
with an ImageMaster VDS system (Amersham Bio-
Table 1
Cell surface markers used for fluorescence activated cell sorting analysis
CD locus and label Detection of MPCs Common name
CD9 FITC Positive Tetraspan
CD44 FITC Positive HCAM
CD54 PE Positive ICAM-1
CD90 biotin Positive Thy-1
CD166 PE Positive ALCAM
CD133 biotin Negative AC133
CD45 FITC Negative Leukocyte common antigen
IgG1 FITC, IgG1 biotin - IgG1 isotype control
IgG2b PE - IgG2b isotype control
The classification mesenchymal progenitor cell specific surface marker was done in conformity with previous publications [6,30]. ALCAM, 
activated leukocyte cell adhesion molecule; FITC, fluorescein isothiocyanate; HCAM, homing cell adhesion molecule; ICAM, intercellular adhesion 
molecule; MPC, mesenchymal progenitor cell; PE, phycoerythrin.Arthritis Research & Therapy    Vol 6 No 5    Fickert et al.
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sciences, Freiburg, Germany). The primer sequences are
shown in Table 2.
Results
Flow cytometric analysis of mesenchymal progenitor 
cells from human osteoarthritic cartilage
No single surface marker protein has yet been found to
characterize MPCs. From the accepted markers, we chose
seven different cell surface markers and used them in triple
combinations for fluorescence-activated cell sorting
(FACS) analysis. Immediately after overnight isolation,
chondrocytes from OC were directly stained with seven tri-
ple combinations of CD9, CD44, CD54, CD90 and
CD166 as positive markers, and CD45, CD133/-1 and -2
as negative markers to eliminate haematopoietic and
endothelial cells (Table 2). The expression of progenitor
typical markers varied from nearly no detectable staining to
relatively high levels of expression. As shown in Fig. 1, in
the forward/side scatter the fresh isolated OC cells were a
heterogeneous population. The majority of the cells stained
negative for CD9, CD90 and CD166. The proportion of
CD9+/CD90+/CD166+ triple positive cells was only about
5%.
CD9+/CD166+ cells could be subdivided in two equivalent
populations comprising about 8% of total cells that were
either positive or negative for CD90. We analyzed CD9- but
CD90+/CD166+, CD90-/CD166+  and CD90-/CD166-
cells, and found that these groups comprised 23.0%,
29.7% and 33.7% of cells, respectively. No CD90+/CD9-/
CD166- cells were detectable.
The isotype control antibody revealed no specific staining.
The distribution of OC cells in forward/side scatter exhib-
ited no difference between isotype and antibody staining. A
maximum of 2% positive cells by staining with isotype anti-
body mouse IG1 or IG2 conjugated with FITC, PE or biotin
was allowed and therefore was used to set the markers
within the channel display. The distinction to negative
assessed cells is presented in Fig. 1 by showing an exem-
plary FITC-isotype antibody mIgG1 staining.
Comparing total quantities of triple positive cells from OA
cartilage (Fig. 2), CD9+/CD44+/CD166+  and CD9+/
CD54+/CD90+ cells were detected in (mean ± standard
deviation) 12.2 ± 10% and 13.3 ± 5.7%, respectively (n =
8). The frequencies of CD9+/CD90+/CD166+ and CD9+/
CD44+/CD54+ cells were 8.2 ± 10.4% and 2.5 ± 1.8%,
respectively.
The combinations CD45+/CD90+/CD166+  and CD9+/
CD133(1 or 2)+/CD166+ exhibited less than 1% staining.
MPC cultures isolated from bone marrow from different
donors served as controls. In these samples 95–98% of all
gated cells were triple positive for various combinations of
the markers CD9/CD54/CD90/CD166 (data not shown).
Analysis of chondrocytes after adherence and cultivation
The change in cellular morphology and the acquisition of a
fibroblastic shape became increasingly apparent as the
cells were cultured on plastic. In the primary culture, non-
adherent or few loosely adherent small round cells were
also present, but these disappeared from the first to the
second passage. After an initial lag time of 2–3 days, cells
entered a proliferative phase, reaching confluence within
48 hours. An average of one doubling every 3 days was
observed upon subsequent passages.
In order to determine the percentage of culture expanded
progenitor cells that express antigens recognized by CD9/
CD44/CD54/CD90/CD166 monoclonal antibodies, the
number of immunoreactive cells was quantified by flow
cytometry. Data from adherent, culture expanded cells
were collected and the number of triple-positive events was
expressed as a percentage of the total cell number. An
example for the distribution of cultured OC cells is shown
in Fig. 3. Compared with fresh isolated OC cells, as seen
in Fig. 1, the cultured cells are a homogeneous population
on forward/side scatter.
In these experiments, the mean frequency of every triple
positive staining of cultured OC cells increased markedly
compared with native OC cells (Fig. 2). The total frequency
of the CD9+/CD90+/CD166+  population rose 4.1-fold
Table 2
Polymerase chain reaction primers
Target Primers
AP 5'-ACC TCG TTG ACA CCT GGA AG-3'
5'-CCA CCA TCT CGG AGA GTG AC-3'
BSP 5'-TGC ATT GGC TCC AGT GAC ACT-3'
5'-TGC TCA GCA TTT TGG GAA T-3'
Col1 5'-TAA CTT CTG GAC TAT TTG CGG ACT TTT GG-
3'
5'-CAA CCT CAG CCC ATT GGC GCT G-3'
GAPDH 5'-CGG AGT CAA CGG ATT TGG TCG TAT-3'
5'-AGC CTT CTC CAT GGT TGG TGA AGA C-3'
OCN 5'-CTG GCC CTG ACT GCA TTC TGC-3'
5'-AAC GGT GGT GCC ATA GAT GCG-3'
For primer design, Primer3 was used (Rozen S, Skaletsky HJ [1998; 
available at http://www-genome.wi.mit.edu/genome_software/other/
primer3.html]), with published DNA sequences from GenBank 
(NCBI). Used parameters: product size 180–600 base pairs, 
annealing temperature 60°C, and primer length 18–30 base-pairs. 
AP, alkaline phosphatase; BSP, bone sialoprotein; Col1, collagen 
type I; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; OCN, 
osteocalcin.Available online http://arthritis-research.com/content/6/5/R422
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compared with freshly isolated OC chondrocytes. After cul-
tivation in monolayer, we found 18.8-fold more CD9+/
CD44+/CD54+ cells than among native, uncultured OC
cells. Analysis of the CD9+/CD44+/CD166+ subpopula-
tion revealed only 1.6-fold expansion, whereas CD9+/
CD54+/CD90+ cells expanded 3.4-fold. Within the in vitro
expanded cells, CD45+ was still not detectable, whereas
the total frequency of CD45-/CD90+/CD166+ population
was around 29–45%. These results indicate that cultiva-
tion enriches a subpopulation of OC cells that express cell
surface markers for MPCs.
Figure 1
Fluorescence activated cell sorting analysis of fresh isolated chondrocytes from osteoarthritic cartilage Fluorescence activated cell sorting analysis of fresh isolated chondrocytes from osteoarthritic cartilage. (a) Forward/side scatter. (b) Markers were 
set in the channel display with a maximum of 2% positive cells by staining with isotype control antibody fluorescein isothiocyanate (FITC)-conjugated 
mouse IgG1. (c-e) Triple staining experiments for CD9-FITC/CD90-allophycocyanine (APC)/CD166- phycoerythrin (PE). Panel c shows a histogram 
of FL1 CD9-FITC. Based on isotype and histogram, cells were divided into positive or negative: panel d, CD9-, double-stained CD90-APC/CD166-
PE; and panel e, CD9+, double-stained CD90-APC/CD166-PE.Arthritis Research & Therapy    Vol 6 No 5    Fickert et al.
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Sorting and cultivation of progenitor marker positive, 
fresh isolated osteoarthritic cartilage cells
Findings in fresh isolated chondrocytes suggested that
there is a subpopulation in OC that expresses progenitor-
associated markers and is capable of osteogenic and
chondrogenic differentiation. If a common progenitor cell
exists, then it should be found among cells with a CD9+,
CD90+  and CD166+  phenotype. Based on phenotypic
analysis by FACS, we therefore isolated CD9+/CD90+/
CD166+ OC cells from five patients and analyzed the kinet-
ics of cultivation and the potential for differentiation. The
data analysis after sorting is exemplarily shown for one
patient in Fig. 4. The gates used for cell sorting are shown
in Fig. 4.
In these experiments, the mean frequency of the native
CD9+/CD90+/CD166+ population was 32%. Figure 4a
shows the forward and side scatter characteristics of
sorted OC cells. To confirm the quality of sorting, reanalysis
of triple positive sorted cells was performed, and it was
found that 99.1% were again triple positive (Fig. 4e). Serial
observations of each culture well that contained triple
positive cells were performed after 3, 7, 14, 21 and 28
days. The earliest point at which the growth of triple posi-
tive sorted could be detected was after 3 days. Between 7
and 14 days of culture, adherent, fibroblast-like cells
scattered in a random pattern across the surface of the cul-
ture well. For 21 days of culture, continuous growth of the
adherent, fibroblastic cells was observed.
Differentiation of the cultured sorted cells was determined
by RT-PCR, histochemistry and immunohistochemistry.
The findings confirmed that the CD9/CD90/CD166 triple
positive cell population derived from OC was capable of
multipotent mesenchymal differentiation.
Osteogenesis, adipogenesis and chondrogenesis of 
culture expanded osteoarthritic cartilage cells
To study the possible multilineage capacity of some OC
derived cells, we differentiated these cell cultures toward
the osteogenic, adipogenic and chondrogenic lineages.
Pellet cultures of OC derived cells resulted in the formation
of dense nodules consistent with chondrogenic differentia-
tion. These nodules were associated with an Alcian Blue-
positive extracellular matrix, which indicates the presence
of sulphated proteoglycans within the matrix (Fig. 5).
Cartilaginous nodules were also observed upon pellet cul-
tures of bone marrow derived MPCs. In addition to the
presence of sulphated proteoglycans within the extracellu-
lar matrix, transforming growth factor-β3  supplemented
OC-derived cells expressed collagen type II and COMP in
pellet culture (Fig. 5a,5b,5c,5d,5e,5f). Overall, these
Figure 2
Flow cytometric analysis of combinations of progenitor markers on freshly isolated and culture expanded chondrocytes from osteoarthritic cartilage Flow cytometric analysis of combinations of progenitor markers on freshly isolated and culture expanded chondrocytes from osteoarthritic cartilage. 
The label 'native' represents the fluorescence-activated cell sorting analysis after tissue digestion, whereas 'cultivated' indicates the analysis after 
culture expansion. The number of patients used for every analysis is indicated above every box plot. The dot presents the arithmetic mean of all the 
data in the category.Available online http://arthritis-research.com/content/6/5/R422
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results indicate that a subpopulation of OC-derived cells
has the capacity to differentiate toward the chondrogenic
lineage. To determine whether OC cells undergo adipo-
genesis, cells were cultured in medium containing dexame-
thasone, isobutyl-methylxanthine and indomethacin. About
10–30% of the OC cells were reproducibly induced
toward the adipogenic lineage as early as 2 weeks after
induction (Fig. 5g,5h). Using PCR, the expression of
peroxisome proliferator-activated receptor-γ demonstrated
adipogenic differentiation by progenitor marker sorted and
culture-derived OC cells (data not shown).
Differentiation of OC derived cells into osteoblasts was
induced in vitro by treating the cells with ascorbic acid, β-
glycerophosphate and dexamethasone [2,20,21]. OC
derived cells and bone marrow MPCs formed an extensive
network of dense, multilayered nodules that stained posi-
tive for alkaline phosphatase.
Figure 3
Fluorescence-activated cell sorting analysis of culture expanded chondrocytes Fluorescence-activated cell sorting analysis of culture expanded chondrocytes. (a) Forward and side scatter (FCS/SSC) of cultured cells. Histo-
grams of CD9-fluorescein isothiocyanate (FITC) (b) negative and (c) positive stained cells. Dot plots show the expression of triple stained cells: 
CD9-FITC gated (d) negative and (e) positive double-stained CD90-Biotin/CD166-phycoerythrin (PE).Arthritis Research & Therapy    Vol 6 No 5    Fickert et al.
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After 14 days of differentiation, the gene expression profile
of osteoblast markers was investigated. For OC cells and
bone marrow MPCs we detected a strong signal for
expression of genes for all tested osteogenic markers (Fig.
6): alkaline phosphatase, bone sialoprotein and
osteocalcin.
Discussion
We could show that a defined population of MPCs resides
within OC of knee joints. Although these were present only
at a low percentage in native tissue, their relative amount
increased markedly during cell cultivation, indicating that
this subpopulation possibly could be targeted in vivo for
novel tissue regeneration strategies.
In parallel to our findings in joints of osteoarthritic patients
with mean age 74 years, Barbero and coworkers [18]
described the plasticity of clonal populations of dedifferen-
tiated human articular chondrocytes from much younger
probands (mean age 30 years) without degenerative joint
Figure 4
Reanalysis of triple positive sorted cells Reanalysis of triple positive sorted cells. (a) Forward and side scatter characteristics of sorted osteoarthritic cartilage cells. (b-d) CD9-fluorescein 
isothiocyanate (FITC)/CD166-phycoerythrin (PE), CD9-FITC/CD90-allophycocyanine (APC) or CD90-APC/CD166-PE double positive cells and 
the fluorescence gate used for sorting. Triple staining: (e) CD9+/CD90+/CD166+ and (d) CD9-/CD90+/CD166+.Available online http://arthritis-research.com/content/6/5/R422
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disease. This argues against the suggestion that develop-
ment of a plastic phenotype is solely dependent on the
presence or duration of disease. Using a clonal assay, Bar-
bero and coworkers found that about 10% of freshly iso-
lated cells had the capacity to differentiate toward
chondrogenic, osteogenic and adipogenic lineages. This is
in good agreement with our findings based on the
quantification by FACS analysis using triple staining of
MPC related cell surface markers. In addition, Jones and
coworkers [22] recently identified cells with characteristics
of MPCs in synovial fluid of osteoarthritic patients using
FACS analysis and proved their potential to differentiate.
Apart from their functionality, there are several reports on
phenotypic characterization of human bone marrow MPCs
by expression of surface markers [4,8,23,24]. MPCs
express a large number of adhesion molecules such as
activated leukocyte cell adhesion molecule (CD166), the
hyaluronate receptor (CD44) and intercellular adhesion
molecule-1 (CD54), growth factor and cytokine receptors,
integrins and additional markers such as tetraspan (CD9)
and Thy-1 (CD90). In contrast, CD34 and the leukocyte
common antigen CD45, which represent the haematopoi-
etic lineage, are not expressed by ex vivo culture expanded
MPCs. The early haematopoietic lineage is also character-
ized by the expression of CD133 [4,25-27]. Despite
expanding knowledge on the biology of MPCs, until now it
was not possible to characterize these cells using a single
marker. Based on the expression of surface markers, the
progenitor nature of a certain percentage of OC cells was
suggested in our experiments by positive reactivity to a
combination of established markers. For FACS analysis
and cell sorting, we used various triple combinations of the
markers CD9, CD44, CD54, CD90 and CD166. The
amount of total triple positive cells varied to some extent
between the selected combinations, indicating that the
subpopulations – although exhibiting considerable overlap
– are not absolutely identical. The expression of triple com-
binations of MPC typical surface markers, combined with
the plasticity of differentiation, as was shown for the CD9+/
CD90+/CD166+ subpopulation, indicates that the progen-
itor cells identified in OA cartilage have marked similarities
to bone marrow MPCs. However, as a total population,
unlike bone marrow MPCs, cartilage derived cells could not
form bone in an in vivo osteochondrogenic assay [17]. This
may be related, at least in part, to cellular heterogeneity and
a lower percentage of pluripotent cells. The potency of
MPC marker sorted, cartilage derived cells in such in vivo
assays clearly deserves further investigation.
The observed increase in the relative percentage of triple
positive cells after cultivation indicates that the subpopula-
tion of progenitors from OC retained high proliferative
capacity. It has been reported that bone marrow MPCs
from patients with osteoarthritis have reduced adipogenic
Figure 5
Chondrogenesis and adipogenesis of culture expanded and progenitor  marker sorted osteoarthritic cartilage derived cells Chondrogenesis and adipogenesis of culture expanded and progenitor 
marker sorted osteoarthritic cartilage derived cells. Culture expanded 
cells were stained as follows: (a) Alzian blue, (c) collagen type II, (e) 
cartilage oligomeric matrix protein (COMP) and (g) oil-red. The marker 
sorted cells are shown in (b) Alzian blue, (d) collagen type II, (f) COMP 
and (h) oil-red.Arthritis Research & Therapy    Vol 6 No 5    Fickert et al.
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and chondrogenic differentiation potential [28]. Our find-
ings concerning the differentiation of CD9+/CD90+/
CD166+ sorted cells indicate that corresponding progeni-
tor cells derived directly from the affected tissue at least
have retained the potential to enter these lineages. There-
fore, a certain cellular 'regenerative potential' is still present
in OC. Future studies will have to address the important
question of whether this capacity is not adequately used
during early stages of degenerative joint disease or simply
not sufficiently to cover demands.
The evolving concept that cartilage may have an intrinsic
capacity for regeneration challenges a long-lasting
paradigm. However, it has already been mentioned that
chondrocytes may have several options in responding to
injury, including recapitulation of development such as
expression of procollagen type IIA [29]. Possibly, the acti-
vation of MPCs may contribute to the observed expression
of this alternative splice variant. A misguiding of repair
attempts may also lead to either enhanced terminal chon-
drogenic (collagen type X expression) or incomplete oste-
ogenic differentiation, as is observed in OC.
Our observations of an enrichment of subpopulations with
characteristics of MPCs during in vitro cultivation and pro-
liferation also shed new light on the cell biological basis of
chondrocyte transplantation. It may be assumed that the
cell population derived from intact cartilage, which also
contains a certain amount of progenitor cells [18], also
increases in their relative percentage. This could have a
profound influence on differentiation potential. Therefore,
further studies on the proliferation and (re)differentiation
potential of distinct subpopulations are necessary to
improve further the functional quality of the cell populations
used for transplantation. The methods of FACS analysis
and cell sorting offer important approaches for quality con-
trol and application of cell populations with greater purity.
Conclusion
In conclusion, there is increasing evidence for cellular het-
erogeneity of cartilage derived cells in health and disease.
Figure 6
Polymerase chain reaction analysis of osteogenesis of culture expanded and progenitor marker sorted osteoarthritic cartilage derived chondrocytes Polymerase chain reaction analysis of osteogenesis of culture expanded and progenitor marker sorted osteoarthritic cartilage derived chondrocytes. 
AP, alkaline phosphatase; BSP, bone sialoprotein; COL1, collagen type I; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; M, 100 base-pair 
size marker; OCN, osteocalcin.Available online http://arthritis-research.com/content/6/5/R422
R432
The spectrum of cellular phenotypes contains a low per-
centage of progenitor cells that are bipotential or tripoten-
tial for mesenchymal lineage progression. The techniques
of fluorescence automated flow cytometry and cell sorting
using typical combinations of cell surface markers for
MPCs offer powerful tools with which to study the biologi-
cal properties of defined subpopulations and their involve-
ment in disease or repair processes. Of course, additional
studies are necessary to identify the most suitable combi-
nations of cell surface markers for distinct subpopulations
from early to late developmental stages. This knowledge
may provide a basis to improve current approaches of cell
based therapies for cartilage defects and to develop new
strategies for guided tissue regeneration.
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